Viewing Study NCT03709758


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-05 @ 1:16 AM
Study NCT ID: NCT03709758
Status: RECRUITING
Last Update Posted: 2025-01-13
First Post: 2018-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module